aTyr Pharma | LIFE - Operating Profit


aTyr Pharma reported $-26.74M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Ardelyx USD 4.67M 19.07M Sep/2025
aTyr Pharma USD -26.74M 6.43M Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -7.89M 540K Sep/2025
CSL USD 666M 1.31B Jun/2025
Galapagos EUR -41.67M 15.36M Sep/2025
GlaxoSmithKline GBP 2.79B 764M Sep/2025
Grifols EUR 411.56M 15.51M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025